What Canadian healthcare organizations should look for in a Device as a Service programme for clinical devices

Your capital committee rejected the scanner refresh again. The EMR upgrade requires hardware your current fleet can’t run. And your CFO wants a monthly cost model that doesn’t require a three-year capital plan and a board presentation.

You already know Device as a Service (DaaS) exists. You understand the concept—monthly per-device fee, hardware included, lifecycle managed by a third party. What you need now is a framework for evaluating DaaS providers that accounts for the specific complexity of clinical devices in a Canadian health system.

That complexity is real. Canadian hospitals dedicate the vast majority of their budgets to staff compensation. Hospital employee compensation reached $45 billion in 2022–2023—roughly two-thirds of total hospital costs. That’s why the capital committee keeps deferring your device refresh. It’s not that the need isn’t understood. It’s that the budget structure makes technology investment a perennial loser against labour costs, surgical equipment, and building repairs.

This article covers eight evaluation criteria for clinical DaaS providers, structured as a framework you can bring to your next vendor meeting—or use to structure an RFP that separates providers built for secure mobility for clinical teams from providers adapting a generic subscription model.

Why clinical devices need a different DaaS evaluation framework

A hospital IT Director signs a DaaS contract that looks great on paper. The pricing is competitive. The contract terms are clean. Six months later, a barcode scanner fails on a med-surg unit at 7 p.m. on a Thursday. The provider’s spare-pool model is built for next-business-day office laptop swaps, not same-day clinical-floor replacements. A nurse can’t scan patient wristbands for medication administration until Friday afternoon.

That gap between generic DaaS and clinical DaaS is what this evaluation framework addresses.

The scale of mobile device adoption in healthcare has moved past aspirational. Zebra Technologies’ research shows 97% of nurses and 98% of physicians expected to use mobile devices at the bedside by 2022—a global sample, but one that aligns with what we see in Canadian acute care. Bedside mobility is the baseline expectation, which means device downtime on a clinical floor is a patient-safety concern, not just an IT inconvenience.

The same research found that 70% of medical errors are attributable to communication breakdowns. The device in a clinician’s hand isn’t just an efficiency tool—it’s a communication tool. When it fails or runs outdated software, the risk is clinical.

Here’s what actually happens when capital doesn’t get approved for clinical device refresh: consumer-grade phones and tablets get pressed into service. The iPhone a department bought with discretionary funds. The Android tablet someone found on a deal. These consumer devices can’t survive chemical disinfection protocols, don’t have integrated barcode scanners, and can’t be hot-swapped with a pre-staged replacement. The result is a shadow fleet that IT can’t manage and infection control can’t endorse.

The evaluation criteria that follow address the specific requirements that separate clinical DaaS from generic device subscriptions. Apply them as filters, and the field of qualified providers narrows quickly.

Clinical-grade mobile hardware that supports care workflows

If the DaaS provider’s hardware catalogue doesn’t include devices with IP67 ingress protection, compatibility with 30+ hospital-grade chemical disinfectants, hot-swap batteries, and an integrated 1D/2D barcode scanner, the programme is not built for clinical environments. Full stop.

This isn’t about premium pricing or feature lists. It’s about whether the device can survive the actual conditions of clinical use—and whether it can support the workflows that patient safety depends on.

Consumer-grade devices have documented limitations when it comes to clinician performance, total cost of ownership, cleanliness, computing power, and durability. The TCO of a consumer device pressed into clinical service is higher than a purpose-built clinical handheld, because replacement cycles are shorter and workflow disruption is constant.

The clinical case is even more direct. Research from Zebra’s healthcare mobility studies shows a 61% reduction in medication-administration errors and 46% reduction in preventable medical errors after clinical mobility deployment. The right device directly reduces clinical risk—this is a patient-safety argument that belongs in the business case, not just the IT procurement justification.

Here’s what actually happens on the floor: a Zebra HC50 or Honeywell CT30 XP-HC can survive being wiped down with accelerated hydrogen peroxide between every patient interaction. An iPhone in a plastic case cannot. When evaluating a DaaS provider, ask to see the specific device models in their clinical catalogue—and ask how many chemical disinfectants those devices are rated for. If the answer is vague, the provider hasn’t done clinical deployments.

Key hardware specifications to require in your RFP

• IP67 ingress protection (sealed against dust and water immersion)
• Compatibility with 30+ hospital-grade chemical disinfectants, including accelerated hydrogen peroxide
• Hot-swap battery capability for continuous use across shifts
• Integrated 1D/2D barcode scanner (imager, not laser) for wristband and medication scanning
• Wi-Fi 6/6E and optional 5G support for coverage across facility zones
• Dedicated emergency alert button (configurable for duress or code response)
• EMR client certification for Epic Rover, Cerner/Oracle Health, or MEDITECH

PHIPA-compliant mobile device lifecycle—from deployment through decommissioning

The October 2023 ransomware attack on a shared IT vendor knocked five southwestern Ontario hospitals offline for months. The direct cost exceeded $7.5 million, and the personal health information of more than 516,000 patients and employees was compromised. Surgeries were postponed. Cancer radiation treatments were transferred to other facilities. Most systems weren’t restored until February 2024.

That incident didn’t start with a sophisticated nation-state attack. It started with a vendor whose security posture wasn’t adequate for the data it handled.

When you engage a DaaS provider for clinical devices, that provider becomes a PHIPA agent—a third party handling devices that store, transmit, or access personal health information. Under PHIPA, you—as the health information custodian—must bind the DaaS provider by a written agreement addressing PHIPA obligations, including breach notification.

Since January 2024, the stakes have financial teeth. The Ontario Information and Privacy Commissioner can now issue PHIPA penalties of up to $50,000 for individuals and $500,000 for organizations. The DaaS provider’s PHIPA compliance isn’t a nice-to-have. It’s a financial risk factor that belongs in your vendor-assessment scorecard.

PHIPA compliance isn’t a checkbox at the end of the device lifecycle. It applies at staging—what data is loaded onto the device and how it’s protected during configuration. It applies in-life—how PHI is protected on a device in a clinician’s hand, how MDM policies enforce encryption and remote wipe capability. And it applies at end-of-life—how PHI is destroyed when the device is retired.

The IPC’s guidance is specific: PHIPA s. 13(1) requires custodians to destroy PHI “in such a way that it cannot be reconstructed or retrieved.” At end-of-life, the DaaS provider must deliver per-serial-number certificates of data erasure with chain-of-custody documentation—not a batch certificate for 200 devices.

Here’s what actually happens with mixed fleets: standard overwrite methods do not work reliably on solid-state drives (SSDs) or USB flash drives. The magnetic overwrite techniques that work on traditional hard drives leave data exposed on flash-based storage. Organisations wiping mixed fleets of HDDs and SSDs with the same process may be leaving data on every flash-based device without realising it. When evaluating a DaaS provider’s decommissioning process, ask specifically how they handle SSD and flash media.

What a PHIPA-aligned data-sharing agreement should include

Your written agreement with the DaaS provider should address PHIPA agent obligations explicitly: a clear definition of the provider’s role as a PHIPA agent, breach-notification timelines aligned with the IPC’s “first reasonable opportunity” standard (interpreted as within 72 hours), data residency commitments specifying Canadian hosting, audit rights allowing you to verify compliance, and termination provisions that address secure data return and destruction.

Do not rely on the provider’s standard service agreement. The PHIPA agent relationship requires contract language that goes beyond typical commercial terms.

End-of-life destruction standards to require

Require NIST SP 800-88 Rev. 1 certified erasure methods (Clear / Purge / Destroy, with Destroy for devices that cannot be reliably purged). Require NAID AAA certification for the decommissioning facility. For environmental compliance, look for R2v3 or e-Stewards certification. Most importantly, require per-serial-number certificates of destruction with chain-of-custody documentation from the clinical floor to the certified device retirement and secure data erasure process.

Canadian data residency and sovereign service delivery

Most DaaS providers will say they “support Canadian data residency.” The meaningful question is whether their MDM tenant, ticketing platform, service desk recordings, telemetry analytics, and decommissioning chain-of-custody documentation are all hosted on Canadian soil by Canadian-based staff. If the answer to any of those is “no” or “it depends,” the provider’s sovereignty claim has gaps.

The conservative, widely adopted compliance position is clear: store all PHI in Canada, preferably in Ontario. While PHIPA does not explicitly mandate Canadian residency, the IPC’s enforcement posture and the practical expectations of Ontario health-system procurement make Canadian residency the de facto compliance floor.

The operational implications go beyond data storage. PHIPA’s “first reasonable opportunity” breach-notification standard has been interpreted as within 72 hours—far tighter than the 60-day window under the US HIPAA framework. If a DaaS provider’s incident-response team is in another time zone or another country, meeting a 72-hour notification window becomes operationally precarious.

Here’s what actually happens when sovereignty is a marketing claim rather than an operational reality: a device fails on a Friday evening at a northern Ontario hospital. The service desk call routes to a US-based tier-1 team. The agent may not know the difference between PHIPA and PIPEDA. May not speak French. May not have access to Canadian-hosted ticketing to document the incident properly. That’s not a hypothetical—it’s the operational reality when “Canadian support” means a US platform with a Canadian phone number.

The sovereignty checklist—questions to ask every DaaS provider

Before signing a contract, get specific answers to these questions:

• Where is your MDM tenant hosted—which data centre, which country?
• Where is your ticketing system hosted, and who has access to ticket data?
• Where are your service desk agents physically located—city and country?
• Are your staging and kitting facilities located in Canada?
• Can you provide bilingual (English/French) service desk support without call transfer?
• Do you subcontract any lifecycle functions—staging, repair, decommissioning—to offshore providers?

The answers will separate providers with Canadian operational infrastructure from providers with Canadian sales offices and US-based delivery.

Predictable per-device pricing for health system budget cycles

A hospital CFO presents the annual capital plan to the board. Clinical device refresh is item #14 on a list of 20 capital requests, competing against surgical equipment, HVAC upgrades, and a parking-structure repair. The device refresh gets deferred—again. The nursing units keep using scanners that can’t run the new EMR client. The refresh request moves to next year’s capital plan, where it will compete against a new slate of priorities.

This cycle is structural to how Canadian hospitals are funded. Provincial global budgets ring-fence capital spending. The competition for capital isn’t just internal—it’s a function of how the money flows.

The problem is getting worse, not better. Real per-capita public-sector health expenditure declined by –1.4% in 2024. Canadian health systems are spending less per person in real terms. Capital budgets are the first casualty, because labour costs are non-negotiable and consume two-thirds of hospital budgets.

A DaaS model converts the device refresh from a capital fight into an operating-budget line item. The refresh becomes a predictable monthly fee approved once and stable for the contract term—not an annual battle for capital committee attention.

This isn’t just a financial convenience. Research from the Montreal Economic Institute puts it directly: “Public decision-makers generally operate under fixed budgets and intense scrutiny… the dominant strategy is usually to delay new technology.” The structural incentive in Canadian healthcare is to defer technology refresh. DaaS breaks that cycle by embedding refresh into the contract term—the device is replaced at 24, 36, or 48 months regardless of whether the capital committee has approved a new round of spending.

Here’s what actually happens in a capital-purchase model: the hidden costs are everywhere. Staging labour from internal IT, budgeted under personnel. MDM licence renewals on a separate line item. Break/fix funded from a maintenance envelope that’s already stretched. Decommissioning costs that nobody budgeted for because the device was supposed to last another year. A well-structured DaaS contract bundles all of these into a single per-device monthly fee.

The CFO’s question should be: “What’s included and what’s excluded?” The answer should fit on one page.

What “all-in” should actually mean in a clinical DaaS contract

A comprehensive clinical DaaS monthly fee should cover:

• Hardware (clinical-grade device from a specified catalogue)
• MDM licensing and managed MDM administration
• Staging and kitting to hospital specifications (gold image, Wi-Fi profile, EMR client)
• In-life repair and break/fix with defined SLAs
• Spare-pool access with hot-swap capability
• Secure decommissioning with per-serial certificates of destruction
• Device refresh at term (24, 36, or 48 months)

Carrier connectivity may be included or managed separately—this varies by provider. If connectivity is excluded, understand whether you’re managing SIMs and data plans independently or whether the provider offers a carrier-agnostic connectivity add-on. The exclusions matter as much as the inclusions.

The evaluation criteria covered so far—clinical-grade hardware, PHIPA-compliant lifecycle management, Canadian data residency, and predictable pricing—establish the foundation. But the criteria that most sharply separate clinical DaaS from generic device subscriptions are operational: how fast can a failed device be replaced on a clinical floor, and can the provider work with your existing EMR and MDM infrastructure?

Hot-swap logistics and spare-pool models for clinical floors

When a clinical handheld fails mid-shift, the question isn’t “how fast can you ship a replacement?” It’s “is there a pre-staged, pre-enrolled, ready-to-scan replacement already in this building—or within same-day courier distance?”

This is where clinical DaaS separates from generic device subscriptions. A broken laptop on an office desk can wait 48 hours. A broken scanner on a med-surg unit cannot.

The southwestern Ontario hospital outage demonstrated what happens when clinical systems go down for extended periods—surgeries postponed, cancer radiation treatments transferred to other facilities, most systems not restored until February 2024. That was a cyber incident, but the operational lesson applies to any device outage: clinical workflows cannot tolerate multi-day gaps.

Here’s what actually happens with a standard DaaS RMA process: the clinician reports a failed device. A ticket is opened. A replacement ships from a central depot—maybe Toronto, maybe the US. The device arrives in two to four business days. Then internal IT has to enrol it in MDM, load the hospital’s gold image, configure Wi-Fi, install the EMR client, and test it. The clinician gets a working scanner five to seven days after the original failure.

Now compare that to a spare-pool model built for clinical environments: pre-staged devices—already enrolled in the hospital’s MDM, already loaded with the correct EMR client and Wi-Fi profile—sitting in a secure location at or near the facility. When a device fails, the clinician walks to the charge nurse station, picks up a replacement, and scans a patient wristband within minutes. The failed device goes into a return envelope for repair or decommissioning. That’s what “no time for downtime” means on a clinical floor.

The difference between a DaaS provider with a spare-pool model and one with a standard RMA process is the difference between a four-hour swap and a four-day swap. When you’re evaluating providers, the spare-pool logistics model is the single most important operational differentiator.

SLA questions to include in your DaaS RFP

• What is the device-replacement SLA for clinical-floor failures—same day, next business day, or four hours?
• Where are spare-pool devices physically located—on-site at our facility, at a regional depot, or at a central warehouse?
• Are spare-pool devices pre-enrolled in our MDM environment and pre-loaded with our configuration?
• What is the process for a clinician to access a replacement device at 2 a.m.?
• How do you maintain configuration parity between spare-pool devices and the production fleet?

EMR and MDM interoperability across Canadian health systems

A DaaS provider that only supports one MDM platform or one EMR family isn’t a managed mobility partner—it’s a reseller with a subscription wrapper. Canadian health systems run SOTI MobiControl, VMware/Omnissa Workspace ONE, Microsoft Intune, and 42Gears—sometimes more than one across different sites within the same regional health authority. The DaaS provider must work with what’s already deployed, not force a migration.

EMR adoption in Canadian primary care is near-universal—85% of primary care providers have electronic medical records. In acute care, the number is even higher. The clinical handheld must integrate with the specific EMR platform in use—Epic Rover, Cerner/Oracle Health, MEDITECH, TELUS Health PS Suite, OSCAR Pro—not just “support EMR” in the abstract.

Here’s what actually happens during a health-authority amalgamation: two hospital sites come together under a single governance structure. One site runs SOTI MobiControl. The other runs Intune. The clinical device fleet now spans both MDM environments, and migration to a single platform might take 12 to 18 months while the EMR consolidation takes priority. If your DaaS provider only has expertise in one MDM platform, you’re paying for a DaaS subscription and still managing half your MDM internally.

Ask for the provider’s MDM platform certifications. Ask how many concurrent MDM environments they currently manage. Ask what happens if your organization acquires a site running a different MDM than your primary platform. The answers reveal whether the provider can adapt to your operational reality or whether you’re adapting to their limitations.

Platform-agnostic vs. platform-locked—what to watch for

Carrier-bundled DaaS programmes often lock you to a single MDM platform—typically the carrier’s preferred solution. OEM DaaS programmes may lock you to a single hardware family—Zebra devices only, or Honeywell devices only. Independent managed mobility services providers typically support multiple MDM platforms and multiple hardware OEMs, giving you flexibility as your environment evolves.

When evaluating providers, ask: “If we change MDM platforms in two years, what happens to our DaaS contract?” The answer tells you whether you’re buying a service or buying into a lock-in.

Procurement compliance—navigating BPS, Buy Ontario, and GPO pathways

For Ontario hospitals and other Broader Public Sector organisations, a DaaS contract above $121,200 requires a competitive procurement process. That threshold was raised from $100,000 on January 1, 2024, but most clinical DaaS contracts for a hospital or regional health authority will still exceed it.

The fastest path to a compliant DaaS engagement is often through an existing GPO vendor-of-record arrangement—Mohawk Medbuy, HealthPRO Canada, or Kinetic GPO—rather than a standalone RFP. Mohawk Medbuy manages over $3 billion in spend under contract with hundreds of Canadian healthcare facilities. A DaaS provider already on a GPO vendor-of-record can be engaged faster and with less procurement overhead than one requiring a new competitive process.

The procurement landscape shifted again on April 13, 2026, when the Buy Ontario Procurement Directive came into force under the Buy Ontario Act. For Ontario BPS buyers, the Directive requires preference to Canadian and Ontarian suppliers where possible, subject to trade-agreement obligations under CFTA and CETA.

This isn’t a patriotic sentiment—it’s a codified procurement requirement. A Canadian-headquartered DaaS provider with Canadian operations now has a structural procurement advantage. Selecting a US-based provider may require additional justification under the Directive. Your procurement team will want to know the provider’s corporate domicile and operational footprint before they approve a shortlist.

Here’s what actually happens when procurement isn’t part of the DaaS evaluation: a hospital IT Director finds the right provider through a Google search. The contract value exceeds $121,200. The provider isn’t on a GPO vendor-of-record. Now the hospital is looking at a three-to-six-month RFP cycle before a single device is deployed—and the refresh that was supposed to happen this quarter gets pushed to next fiscal year. The procurement pathway should be part of the DaaS evaluation, not an afterthought.

What a strong clinical DaaS programme looks like in practice

After evaluating the criteria above, here is what a strong clinical DaaS programme delivers for a Canadian health system. Use this as a benchmark when scoring RFP responses.

A provider that meets all seven criteria with specific Canadian operational proof points is a provider built for clinical healthcare. A provider that meets four or five and hedges on the others is a provider you’ll be managing around for the length of the contract.

How PiiComm delivers clinical DaaS for Canadian health systems

When these criteria are applied as filters—Canadian data residency, PHIPA-aligned lifecycle management, clinical-grade hardware, SLA-backed hot-swap, MDM platform agnosticism, and GPO procurement readiness—the field of qualified providers narrows significantly.

PiiComm is Canada’s largest pure-play managed mobility services provider and one of the few DaaS providers that meets all seven criteria with in-country Canadian operations.

The healthcare proof point is specific: PiiComm has deployed clinical mobility programmes including modernizing patient care at a major Canadian research hospital with durable, scan-ready mobile computers for nurses. Across all verticals, PiiComm manages 500,000+ devices across thousands of locations—with healthcare as a primary vertical alongside transportation, retail, and government.

The hardware catalogue includes clinical-grade devices from Zebra (HC20/HC25/HC50/HC55, ET40-HC/ET45-HC) and Honeywell (CT30 XP-HC, CT45-HC). PiiComm holds Premier partnership status with Zebra Technologies—the highest partner tier—which means direct access to clinical device inventory and priority support escalation.

The operational infrastructure is entirely Canadian: staging and deployment facilities in Canada, a 24/7 bilingual (English/French) service desk staffed in Canada, in-house certified technicians, and Canadian-hosted data infrastructure. No core operational function is outsourced or offshored. When a device fails at a northern Ontario hospital on a Saturday night, the service desk agent who answers speaks English or French, knows the difference between PHIPA and PIPEDA, and has access to Canadian-hosted ticketing to document the incident.

Secure decommissioning follows NIST 800-88 certified data erasure protocols with per-serial chain-of-custody documentation—not batch certificates for 200 devices. The Spare-in-the-Air programme delivers pre-staged replacement devices shipped same-day for frontline worker continuity. The AIM (Asset Intelligence Manager) portal provides real-time fleet visibility and analytics.

PiiComm’s Device as a Service (DaaS) programme bundles all five service pillars—Strategic Sourcing, Staging & Deployment, Lifecycle Management, MDM as a Service (MDMaaS), and Secure Decommissioning—into a single monthly per-device fee. At the end of the contract term, devices are securely decommissioned and replaced, maintaining fleet currency without the hospital managing refresh cycles or fighting for capital approval.

MDM platform support includes certification on SOTI and 42Gears, with carrier-agnostic connectivity across Bell, Rogers, and TELUS.

Comparing PiiComm to other clinical DaaS options in Canada

PiiComm isn’t the only option. Here’s how the alternatives compare:

Carrier-bundled programmes (Bell, Rogers, TELUS): Strong on connectivity and device financing. TELUS Health has the deepest healthcare integration through PS Suite and clinical applications. However, carrier device-financing typically bundles device cost into a 24-month rate plan but excludes MDM administration, clinical staging and kitting, spare-pool logistics, and certified end-of-life destruction. The carrier is a connectivity provider with a device subsidy—not a lifecycle manager.

OEM programmes (Zebra OneCare, Honeywell Edge Services): Strong on hardware warranty and repair. However, OEM programmes are hardware-centric—they don’t manage MDM, don’t provide a Canadian service desk, don’t handle carrier connectivity, and don’t issue PHIPA-aligned decommissioning certificates. They’re a component of a DaaS programme, not a DaaS programme.

In-house lifecycle management: Viable for large academic health science centres with dedicated mobility teams and existing staging infrastructure. The limitations are well documented: capital lumpiness creating refresh cliffs, inconsistent device images across amalgamated sites, compliance gaps at end-of-life (particularly with SSD and flash wiping), and hidden labour costs that are never measured as device cost.

PiiComm is the independent, carrier-agnostic, full-lifecycle option with Canadian sovereign delivery—the provider that fills the space between carrier device plans and in-house management.

Talk to a PiiComm mobility specialist about clinical DaaS for your health system →

Questions to ask any DaaS provider before signing a clinical device contract

Before signing a clinical DaaS contract, ask every provider these questions. The answers will separate providers built for healthcare from providers that have adapted a generic DaaS model.

1. What clinical-grade device models are in your hardware catalogue, and how many chemical disinfectants are they rated for?
2. Will you sign a PHIPA-compliant data-sharing agreement and breach-notification clause with a 72-hour response commitment?
3. Where are your MDM tenant, ticketing system, and service desk physically located—city and country?
4. What is your hot-swap SLA for a clinical-floor device failure—same day, next business day, or four hours?
5. Are you on a vendor-of-record with Mohawk Medbuy, HealthPRO Canada, or another GPO?
6. What is included in the monthly per-device fee, and what is excluded?
7. What MDM platforms do you currently manage, and can you support concurrent MDM environments during a site amalgamation?
8. What is your end-of-life data-destruction process, and will you provide per-serial certificates of erasure with chain-of-custody documentation?
9. Can you provide three Canadian healthcare references at comparable scale?
10. How do you handle device refresh at term—who owns the asset, and what is the transition process?

Print this list. Bring it to your next vendor meeting. The providers who answer with specifics—facility locations, certification numbers, named references—are the providers who have done this work. The providers who answer with generalities are the providers you’ll be managing around.

Download the DaaS evaluation checklist →

Frequently asked questions about Device as a Service for healthcare in Canada

What should be included in an all-in monthly DaaS fee for clinical devices?

A comprehensive clinical DaaS fee covers hardware, MDM licensing, staging and kitting to hospital specifications, in-life repair and break/fix, spare-pool access with SLA-backed hot-swap, secure decommissioning with per-serial certificates, and device refresh at term. PiiComm’s DaaS model bundles all five service pillars into a single monthly fee. Carrier connectivity may be included or managed separately—ask what’s excluded.

How does PHIPA affect the choice of a DaaS provider for clinical devices?

Any third party handling PHI on behalf of a health information custodian must be bound by a written PHIPA-compliant data-sharing agreement. The DaaS provider becomes a PHIPA agent—their compliance is your compliance. Since January 2024, the IPC can levy penalties up to $500,000 per organisation for PHIPA violations. Require PHIPA-specific contract language and 72-hour breach notification.

Does a DaaS provider need to store data in Canada?

The conservative, widely adopted compliance position is to store all PHI in Canada. While PHIPA doesn’t explicitly mandate Canadian residency, the IPC’s enforcement posture makes Canadian residency the de facto compliance floor. Ensure the provider’s MDM tenant, ticketing system, telemetry, and service desk recordings are all hosted on Canadian infrastructure by Canadian-based staff.

What is the difference between carrier device financing and a full-lifecycle DaaS programme?

Carrier device-financing from Bell, Rogers, or TELUS bundles device cost into a rate plan but typically excludes MDM administration, clinical staging, spare-pool logistics, and certified decommissioning. A full-lifecycle DaaS programme includes all of these under a single monthly fee. The carrier plan is one component; DaaS is the complete service wrapper.

How fast should a DaaS provider replace a failed clinical device?

For clinical-floor devices, require a same-day or four-hour hot-swap SLA with pre-staged, pre-enrolled replacement devices. A next-business-day SLA is acceptable for back-office devices but not for bedside scanners or clinical handhelds used in medication administration. Clinical workflows cannot tolerate multi-day device gaps.

Can a hospital use its existing MDM platform with a DaaS provider?

A strong DaaS provider supports the hospital’s existing MDM platform rather than requiring migration. Canadian health systems run SOTI, Workspace ONE, Intune, and 42Gears—sometimes multiple platforms across amalgamated sites. Ask for the provider’s MDM certifications and whether they can manage concurrent MDM environments during transitions.

How should clinical devices be securely decommissioned under PHIPA?

PHIPA s. 13(1) requires destruction “in such a way that it cannot be reconstructed or retrieved.” Require NIST SP 800-88 Rev. 1 certified erasure, NAID AAA certification, and per-serial-number certificates of destruction with chain-of-custody documentation. Standard overwrite methods don’t work reliably on SSDs—ask specifically how the provider handles flash-based storage.

Can a hospital procure DaaS through a GPO like Mohawk Medbuy or HealthPRO Canada?

Yes—and it’s often the fastest compliant procurement pathway. A DaaS provider already on a GPO vendor-of-record can be engaged without a standalone RFP, provided the contract value and terms align with the GPO agreement. Ask the DaaS provider which GPO and SSO relationships they hold before starting a procurement process.

The clinical floor doesn’t wait for capital approval

The device refresh your nursing units need isn’t competing against other technology projects. It’s competing against surgical equipment, building infrastructure, and every other capital request on a list that gets longer every year. That structural reality isn’t going to change.

What can change is how you procure and manage clinical devices. A DaaS model built for healthcare—with clinical-grade hardware, PHIPA-aligned lifecycle management, Canadian operational sovereignty, and SLA-backed spare-pool logistics—converts the capital fight into a predictable operating expense. The devices get refreshed on schedule. The clinicians get tools that work. The CFO gets cost certainty.

The evaluation framework in this article gives you the criteria to separate providers built for clinical environments from providers adapting a generic subscription model. Apply them as filters. Ask the questions. The providers who answer with specifics are the ones worth shortlisting.